Strongbridge Biopharma plc Announces Issuance of Patent for RECORLEV® (levoketoconazole) for the Treatment of Cushing’s Syndrome by Carolyn Helms | Jun 3, 2021 | Portfolio News
Theseus Pharmaceuticals Appoints Brad Dahms as Chief Financial Officer by Carolyn Helms | Jun 2, 2021 | Portfolio News
Axonics® Receives FDA Approval Further Expanding MRI Labeling by Carolyn Helms | May 20, 2021 | Portfolio News
Axonics® Announces CE Mark Approval for Implantable Sacral Neurostimulator that Significantly Extends Recharge Interval by Carolyn Helms | May 18, 2021 | Portfolio News
Vera Therapeutics Announces Pricing of Initial Public Offering by Carolyn Helms | May 13, 2021 | Portfolio News
